Seeking Alpha
 

Zoetis (ZTS)

- NYSE
Show Summaries  |  Hide Summaries
  • Fri, Jun. 26, 11:04 AM
  • Dec. 4, 2014, 7:24 AM
  • Nov. 11, 2014, 4:16 PM
  • Nov. 11, 2014, 3:48 PM
  • Sep. 3, 2014, 9:11 AM
    | Comment!
  • Jul. 5, 2013, 9:49 AM
    More on BofA's Zoetis (ZTS +2.8%) upgrade which has the shares trading solidly higher on the session: Analyst Robert Willoughby likes the prospects for EBITDA margin improvement in the coming years as a new ERP system and "changes in manufacturing and supply chain processes" should help reduce inventory.
    | Comment!
  • May 22, 2013, 8:18 AM
    Pfizer (PFE) plans to spin off its remaining stake in Zoetis (ZTS) through a tax-free exchange offer in which Pfizer owners can exchange their Pfizer shares for stock in Zoetis owned by Pfizer (got that?). Pfizer has received a waiver of the 180-day lock-up from the book runners of the Zoetis IPO. PFE +2.1%, ZTS -1.2% premarket. (PR)
    | 11 Comments
  • Feb. 3, 2013, 3:18 AM
    Pfizer (PFE) animal-health spin-off Zoetis (ZTS) forecasts annual growth of 5.7% through 2016, CEO Juan Ramon Alaix tells Bloomberg. He points out that drug failure rates are lower than with human medicines, as there are fewer safety concerns and because animals don't live as long. "Side effects are very rare in our industry, especially in livestock," Alaix says. Zoetis had a stonking NYSE debut on Friday, jumping 19% to close at $31.01 for a market cap of $15.51B.
    | 1 Comment
  • Feb. 1, 2013, 10:22 AM
    Zoetis (ZTS) opens at $31.50, rising 21% from its $26 initial pricing last night - which had already been priced above the expected range of $22 to $25 due to high demand. The animal nutrition spinoff from Pfizer (PFE) raised $2.2B, making it the largest IPO from a U.S. firm since Facebook.
    | 3 Comments
  • Feb. 1, 2013, 9:50 AM
    Pfizer's (PFE) animal-health spinoff, Zoetis (ZTS) is indicated to open in the $30-$32 range after pricing at $26 last night. Pfizer retains an 80% stake in the company.
    | 2 Comments
Visit Seeking Alpha's
ZTS vs. ETF Alternatives
Company Description
Zoetis Inc discovers, develops, manufactures & commercializes animal health medicines & vaccines for livestock & companion animals. Its products include anti-infectives, vaccines, parasiticides, medicated feed additives & other pharmaceutical products.